AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

DOLUTEGRAVIR SODIUM in Zimbabwe

6 products registered with MCAZ β€” 6 active

Brand / ProductReg. No.HolderStatusExpires
DOLUTEGRAVIR SODIUM
TABLET, COATED; ORAL
2019/7.13/5923LAURUS LABS LIMITEDactive14 Mar 2029
MYLTEGA DT
TABLET, COATED; ORAL
2021/7.13/6164MYLAN LABORATORIES LIMITED [OTL]active5 Dec 2028
INSTGRA
TABLET, COATED; ORAL
2019/7.13/5770EMCURE PHARMACEUTICALS LTDactive13 Nov 2028
DOLUTEGRAVIR SODIUM
TABLET, COATED; ORAL
2022/7.13/6359MACLEODS PHARMACEUTICALS LIMITEDactive1 Nov 2028
TIVICAY
TABLET; ORAL
2021/7.13/6129GLAXOSMITHKLINE S.A (PTY) LTDactive31 Dec 2027
DOLUTEGRAVIR SODIUM
TABLET, COATED; ORAL
2024/7.13/6567STRIDES PHARMA SCIENCE LIMITEDactive31 Dec 2027

DOLUTEGRAVIR SODIUM β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 6 registered products containing DOLUTEGRAVIR SODIUM, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track DOLUTEGRAVIR SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Dolutegravir Sodium β€” Zimbabwe (MCAZ) | AfricaRegulatory